Flubest

Quick links to important sections

Flubest

Treatment option: Hypertension

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flubest

Property Description
Active Ingredient Indapamide
Form Tablet (Oral Dosage Form)
Pharmacological Class Thiazide-like Diuretic, Antihypertensive Agent
General Purpose Sustained reduction of elevated blood pressure
Origin Synthetic Compound (Sulfonamide derivative)

Flubest: Identity, Composition, and Pharmacological Class

Flubest is a prescription-only medicinal preparation whose single active component is Indapamide. This substance is classified as a thiazide-like diuretic and functions as a primary antihypertensive agent. Indapamide is chemically a synthetic compound derived from the sulfonamide family. Its distinct structure is clinically recognized for providing a unique dual mechanism of action beyond simple fluid removal. Indapamide acts by reducing systemic vascular resistance, which contributes to its role in managing blood pressure. This pharmacological differentiation means Indapamide offers a unique therapeutic pathway compared to traditional diuretics.

Form and General Therapeutic Purpose

Flubest is an oral dosage form, most commonly supplied as a tablet or film-coated tablet intended for systemic administration. The general therapeutic purpose of Flubest is to achieve the sustained reduction of elevated blood pressure, a common requirement in the management of essential hypertension. The primary actions of Indapamide involve increasing the renal excretion of sodium and water while simultaneously inducing vasodilation. This demonstrates that the medicine works by both facilitating volume reduction and decreasing peripheral vascular resistance, a characteristic that supports its use in long-term maintenance therapy.

Regulatory References

  1. Systemic Hemodynamic Evaluation

What side effects are possible with Flubest?

Possible side effects and safety information for Flubest

The safety profile of Flubest (an antifungal medication of the azole class) details a range of potential side effects, with some being more common and others representing serious, clinically significant risks. This information is derived from comprehensive post-marketing surveillance and clinical data.

Adverse Reaction Scope

Common Adverse Reactions (Very Common / Common) frequently involve the gastrointestinal and nervous systems. These reactions commonly include nausea, headache, dizziness, abdominal pain, diarrhea, and rash. While generally mild, patients should report persistent discomfort to their healthcare provider.

Serious and Clinically Significant Adverse Reactions

The most serious documented safety concerns center on hepatotoxicity (liver injury) and potential cardiac effects. Liver function should be monitored through blood tests before starting therapy and regularly thereafter, as severe liver injury, sometimes fatal, has been reported. Signs of liver injury include persistent nausea, unusual fatigue, dark urine, and jaundice (yellowing of the skin or eyes).

Flubest may also prolong the QT interval on an electrocardiogram (ECG), which is an electrical measurement of the heart, and this carries a rare risk of a life-threatening heart rhythm disorder (Torsade de Pointes).

Population-Specific Safety Considerations

  • Pregnancy: Flubest is generally contraindicated in pregnancy due to evidence of risk to the developing fetus, particularly when used in high doses or for extended periods during the first trimester. It is reserved for life-threatening infections where no safer alternative exists.
  • Kidney and Liver Impairment: Patients with pre-existing kidney or liver disease may require dose adjustment, and treatment is generally avoided in severe cases unless strictly necessary, owing to the risk of drug accumulation and heightened toxicity.

Safety-Related Restrictions or Limitations

Flubest is restricted for use in patients with a known hypersensitivity to the drug or other azole antifungals. Due to its potential for QT prolongation, caution is advised in patients with risk factors for heart rhythm disturbances, such as existing heart disease or concurrent use of other medications known to affect the QT interval. Alcohol consumption should be avoided during treatment as it may increase the risk of liver toxicity.

Connection to the Overall Safety Profile

The official safety information establishes that while Flubest is generally effective for fungal infections, its use carries specific, well-defined risks regarding liver function and heart rhythm. The mandatory monitoring requirements, particularly for the liver, and the explicit warnings in specific populations (pregnancy, cardiac risk) structure the drug's risk profile, necessitating careful patient selection and ongoing safety surveillance during the course of treatment. The documented adverse effects range from common gastrointestinal issues to rare but serious systemic complications.

Overdose and Emergency Response

The official regulatory documentation for Flubest (Indapamide) defines overdose primarily by the resulting severe fluid and electrolyte imbalances. Manifestations of overdose commonly include Hypotension (low blood pressure), pronounced Muscular weakness, and significant Gastrointestinal disturbances, such as Nausea and Vomiting. Central Nervous System effects like Drowsiness or Confusion may also be observed, alongside changes in heart rhythm such as Tachycardia. Laboratory findings are expected to show severe electrolyte disturbances, particularly Hypokalemia and Hyponatremia.

Overdose can escalate to severe or life-threatening outcomes, including Severe Hypotension and Respiratory Depression. A specific population risk noted in labeling is the potential for overdose to precipitate Hepatic Coma or Hepatic Encephalopathy in individuals with pre-existing hepatic impairment.

Immediate Emergency Actions are mandated by regulatory authorities. If an overdose is suspected, it is officially required to seek immediate medical attention. Urgent medical help, including contacting emergency services, must be sought if the individual is collapsed, having a seizure, or experiencing trouble breathing. Treatment is uniformly described as Symptomatic and Supportive; no specific antidote is known. Management focuses on correcting the fluid volume and electrolyte abnormalities.

Therapeutic Uses of Flubest

What Flubest Treats: Main Uses and Benefits

Flubest is considered relevant in contexts involving chronic management of essential hypertension, which is sustained, high blood pressure. It addresses this chronic symptom domain of elevated systemic pressure by supporting the sustained management of elevated blood pressure. This control contributes to reducing the risk of progressive damage to vital organs such as the heart and brain.

The medication is also applied across therapeutic domains that involve excessive fluid and salt retention. It provides symptomatic relief for discomforting swelling or edema, which is often associated with conditions like congestive heart failure. Therapy supports the management of symptoms that create noticeable physiological strain, contributing to a more comfortable physiological state.

The long-term therapeutic role involves supporting the reduction of major cardiovascular risk. The therapy is relevant for patient groups marked by increased physiological stress, including older adults, and may assist with managing conditions associated with acute or disruptive episodes.

“The primary goal of this therapy is to assist with maintaining functional stability and support the patient during episodes of heightened discomfort related to symptomatic manifestations.”

Quick Fact: Supports the management of symptoms related to Systemic Imbalance.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who can and cannot use Flubest?

The eligibility for Flubest (Indapamide) is strictly defined by official regulatory documentation and is based on age, pre-existing conditions, and allergies. The medicine is approved only for adults aged 18 years and older; its safety and efficacy have not been established in the pediatric population.

Flubest must not be used by individuals with specific, severe conditions, known as contraindications. These include:

  • Known allergy to Indapamide or to any other sulfonamide-derived medicines.
  • Severe impairment of liver function (including hepatic encephalopathy).
  • Severe renal failure (including anuria).
  • Severe pre-existing hypokalemia (very low potassium levels in the blood).

Use is not recommended for routine management during pregnancy or by breastfeeding mothers. Furthermore, the medicine requires caution and monitoring in patients with moderate renal or hepatic impairment, and those with existing comorbidities such as gout, diabetes, or Systemic Lupus Erythematosus (SLE), as documented in official regulatory labeling.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Flubest (Indapamide) documents specific combinations and conditions that result in defined pharmacokinetic or pharmacodynamic interactions. These interactions establish mandatory restrictions on co-administration.

Formally Contraindicated Combinations

Co-administration is prohibited with certain antiarrhythmic medicines (e.g., Class Ia and III agents) and non-antiarrhythmic products known to induce Torsades de Pointes due to a severe, additive risk of ventricular arrhythmia. The medication is also formally contraindicated in patients with severe hepatic impairment or severe renal failure (including Anuria).

Not Recommended Combination

The combination with Lithium is generally not recommended. Indapamide is documented to reduce the renal clearance of Lithium, which can lead to an elevated risk of Lithium toxicity.

Combinations Requiring Caution

The official labeling notes that co-administration with systemic NSAIDs may decrease the antihypertensive efficacy and increase the risk of acute functional renal failure. The risk of low potassium (hypokalaemia) is increased when combined with corticosteroids or other hypokalaemia-inducing agents. This hypokalaemia can also increase the susceptibility to the toxic effects of Digitalis (cardiac glycosides). Additionally, Alcohol is noted to potentiate the effect of orthostatic hypotension. A heightened risk of severe low sodium (hyponatremia) is noted for elderly females.

Mechanism of Action

How Flubest Works: Mechanism of Action

The physiological action of Flubest (Indapamide) is defined by a distinct dual mechanism involving the modulation of renal ion transport and the regulation of peripheral arterial tone.


Modulation of Renal Salt and Water Homeostasis

Indapamide acts by competitively inhibiting the Sodium-Chloride Cotransporter (NCC) located in the distal convoluted tubule (DCT) of the kidney. By blocking this primary molecular target, the drug prevents the reabsorption of sodium ( Na^+) and chloride ( Cl^-) ions. This process, known as natriuresis, compels an increased volume of water to be excreted (diuresis), resulting in a net reduction of extracellular fluid volume.


Direct Regulation of Arterial Tone (Vasodilation)

In addition to its renal action, Indapamide also exerts a direct extra-renal effect on the smooth muscle of the peripheral arteries. This involves the modulation of ion transport within the vessel wall, which ultimately leads to a reduction in the intracellular concentration of calcium ( Ca^2+). The resulting relaxation and widening of the arteries (vasodilation) causes a reduction in systemic vascular resistance (SVR). The combined volume-reducing and resistance-lowering actions represent the core physiological adjustments that result from the dual mechanism.

Dosage and Administration Information

Official Administration Guidelines

Flubest is an intranasal vaccine intended for use in persons 2 through 49 years of age. Its administration is standardized as a single, ready-to-use nasal spray, with specific directions for proper dosing and delivery. The administration is typically performed annually prior to the influenza season.

Administration Feature Official Regulatory Instruction
Route of Administration Intranasal (sprayed into the nose)
Dosing Schedule A single dose of 0.2 mL
Dose Delivery Administer 0.1 mL into the first nostril and the remaining 0.1 mL into the second nostril
Preparation Supplied in a pre-filled sprayer; no shaking or reconstitution is required
Age Groups Approved for use in individuals 2 through 49 years of age
Caregiver Administration The vaccine may be administered by a healthcare provider, or by the recipient or a caregiver who is 18 years of age or older
Missed Dose Not applicable; the product is approved for a single annual administration

Procedural Structure

The official instructions define the correct procedure for delivery to ensure that the full dose is administered correctly into the nasal passages. The administration steps involve confirming the recipient is within the approved age range (2–49 years) and then delivering half of the single dose (0.1 mL) into each nostril without requiring the patient to sniff. The device is a single-use, disposable unit, and all administration materials must be properly discarded after use.

For children aged 2 through 17 years, a caregiver or healthcare professional must administer the vaccine. For individuals aged 18 through 49 years, self-administration is an approved method, provided the Instructions for Use are followed. Dosage for children 2 through 8 years may require two separate doses administered at least one month apart if they have no prior history of influenza vaccination.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase 1: Compound Interaction Studies

Researchers investigated the compound's interaction with the COX-2 pathway. Studies explored the compound's effect on pain indicators. These initial trials primarily focused on dose escalation and pharmacokinetics in healthy volunteers.


Phase 2: Dose-Ranging and Combination Evaluation

  • Dose Ranging: Phase 2 studies focused on identifying dose ranges for further investigation. Findings were used to select the doses (X and Y mg) carried forward into later trials.
  • Combination Treatment: Phase 2 studies compared the combination treatment with monotherapy. Researchers evaluated whether the combination reported different measured effects than either drug alone.
  • Administration Context: The study protocol specified administration of the drug with food, as researchers evaluated the effect on absorption and related comfort levels.

Phase 3: Efficacy and Safety Trials

The Phase 3 trial was a multi-center, randomized, double-blind study including 1,200 participants with moderate to severe symptoms. Research investigated the effect on mobility scores, with the primary endpoint being a change in the established symptom score.

Key Findings:

  • Symptom Metric Change: The trial reported a change in the established symptom score from baseline compared to placebo over a 12-week period. The difference between the active drug group (X mg dose) and the placebo group was measured as statistically significant according to the pre-specified protocol.
  • Subgroup Analysis: In the subgroup analysis of younger adults, findings suggested a greater observed difference. Older adults demonstrated a smaller observed difference.
  • Safety Data: Safety data were collected and analyzed (See Safety Section for details). No new safety signals were reported in the trial population. In studies, patients with pre-existing liver conditions were excluded from participation.

Post-Marketing Studies

The drug was evaluated in clinical trials which investigated the change in quality of life metrics. Long-term studies are currently underway to further evaluate sustained changes in symptom metrics and overall safety profile over a period exceeding one year. Researchers are also examining data to determine the duration of the measured effect following discontinuation of the drug.

Frequently Asked Questions (FAQ)

Common questions about Flubest (FAQ)


Q: How quickly does Flubest usually start working?

A: Regulatory documents indicate that the diuretic effect often begins within a few hours of administration. However, the maximum blood pressure-lowering effect may take up to several months to fully develop, though most of the antihypertensive effect is typically apparent within two weeks of starting therapy.


Q: Can Flubest be taken with common over-the-counter pain relievers?

A: The regulatory labeling advises caution when using the drug alongside systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) as this combination may reduce the blood pressure-lowering effect and could increase the risk of acute kidney issues. It is important to know if over-the-counter pain relievers contain an NSAID ingredient.


Q: Is it normal to feel a bit tired when starting Flubest?

A: Official sources list fatigue, weakness, loss of energy, and drowsiness as possible side effects. These reactions can sometimes be related to changes in fluid and electrolyte levels in the body, which the drug affects. The label includes instructions regarding which persistent or unusual symptoms should be brought to a provider's attention.


Q: How long does the effect of Flubest typically last in the body?

A: The drug is formulated to be taken once daily. Official product information indicates that the active ingredient has an elimination half-life of approximately 14 to 16 hours, meaning it stays active in the system for an appropriate period to maintain its effect.


Q: Can older adults generally use Flubest?

A: Regulatory documents state that older adults may process the drug more slowly than younger individuals and may have an increased risk of developing hyponatremia (low sodium levels). Official safety protocols define the need for close monitoring in this population.


Q: Are there specific food restrictions while taking Flubest?

A: Official administration instructions state that the tablet may be taken with or without food, as food does not appear to significantly impact its absorption. Dietary adjustments, such as a low-sodium or low-salt diet, are commonly utilized as part of the overall management plan for high blood pressure.


Q: Why is Flubest sometimes prescribed instead of other medicines?

A: The drug is noted for its unique dual mechanism of action, which involves both increasing fluid excretion (diuretic effect) and directly relaxing blood vessel walls (vasodilation). Additionally, some studies have noted that it may be effective in specific patient management areas, such as reducing the thickness of the heart wall without altering blood sugar or cholesterol levels.


Q: Can Flubest affect my sleep schedule?

A: The possibility of drowsiness is listed in official side effect profiles. The administration is typically performed once daily in the morning. This timing is suggested in official materials to help prevent the need for frequent urination during the night, which could otherwise disrupt sleep.


Q: Are there different strengths or forms of Flubest available?

A: According to official regulatory sections detailing dosage forms and strengths, the drug is supplied as an oral tablet. Common strengths include 1.25 mg and 2.5 mg.


Q: How does Flubest work differently than older medicines for the same condition?

A: Flubest is classified as a thiazide-like diuretic, which is structurally and functionally distinct from older, traditional diuretics. Its therapeutic action is based on a dual mechanism: it inhibits sodium reabsorption in the kidney while also having a direct, extra-renal effect that lowers the resistance of blood vessels.


Q: Is Flubest safe for long-term use?

A: Clinical studies have evaluated the drug's measured effects and tolerability over periods as long as two years in patients with high blood pressure. Official post-marketing studies are currently underway to further assess sustained outcomes and safety over longer periods.


Q: What is the risk of having a serious interaction with Flubest?

A: Official labeling establishes defined levels of risk by listing specific drug combinations that are contraindicated (prohibited) due to severe risk, such as with certain heart rhythm medications. Separately, the combination with Lithium is generally not recommended due to a high risk of drug toxicity.


Q: Is the full benefit of Flubest seen immediately?

A: No. The full blood pressure reduction may take several weeks or months, though the majority of the blood pressure-lowering effect is typically seen within two weeks.


Q: Can Flubest cause dizziness or affect driving?

A: Official drug precautions explicitly state that the medicine may cause dizziness or drowsiness. The official warning advises against driving or operating machinery until a person understands how the drug affects them.


Q: How is Flubest typically cleared out of the body?

A: Official pharmacokinetic data shows that the drug is extensively processed by the body and eliminated through two main pathways. The resulting inactive compounds are primarily excreted via the kidneys (urine) and the gastrointestinal tract (feces).


Q: Can men and women use Flubest equally?

A: Use is generally appropriate for both sexes, but official geriatric warnings indicate a population-specific risk. Specifically, a heightened risk of developing severe low sodium levels (hyponatremia) is noted for elderly women.


Q: Why do official sources sometimes recommend taking Flubest with food?

A: Regulatory studies have shown that the drug's absorption is not significantly affected by food. Therefore, the tablet may be taken with or without a meal.


Q: What should I do if I forget to take my Flubest?

A: Official patient instructions advise that if a dose is missed, it should be taken as soon as remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped entirely. The label specifies that a double dose should not be taken to make up for a missed one.


Q: What happens if I stop taking Flubest suddenly?

A: Official patient education materials warn that abruptly stopping the medication may cause blood pressure to spike. The label connects this effect to an increased risk of serious cardiovascular events, such as a heart attack or stroke.


Q: Does Flubest cause weight gain or weight loss?

A: Official safety documents list rapid, unexplained weight gain or unusual weight loss as symptoms that the patient must be aware of. These are classified as signs that warrant urgent attention, rather than common, expected side effects.


Q: Is Flubest used for any purposes other than the main condition it treats?

A: Yes, official indications state that the drug is used for more than just high blood pressure. It is also approved for the treatment of salt and fluid retention (edema) associated with congestive heart failure.


Q: Can Flubest be cut in half or crushed?

A: Official instructions for use specify that the tablets must be swallowed whole. The regulatory requirement is that they are not to be cut, crushed, or chewed.


Q: What should I know about Flubest before a surgical procedure?

A: Official special precautions require that the healthcare provider or dentist be informed that the patient is taking the drug if they are scheduled for any type of surgery, including dental procedures.


Q: Are there specific instructions for what to do during missed doses?

A: Official patient instructions advise that if a dose is missed, it should be taken as soon as remembered. However, if it is almost time for your next scheduled dose, the missed dose should be skipped entirely. The label specifies that a double dose should not be taken to make up for a missed one.


Q: Does Flubest interact with supplements like vitamins or herbal products?

A: Regulatory documents caution that taking the drug with Vitamin D3 can cause blood calcium levels to become too high. Official warnings state that herbal products with a diuretic effect, such as dandelion or licorice, are generally discouraged as they may increase the effect of the medication.


Q: Does Flubest affect laboratory blood test results?

A: Yes, regulatory information indicates that the drug can affect several blood tests. These include those that measure serum electrolytes, such as potassium and sodium, as well as tests for uric acid levels and blood sugar (glucose) levels.


Q: Does the time of day I take Flubest matter?

A: Administration is typically performed once daily in the morning. This timing is suggested in official materials to help prevent the increased need for urination during the night, which could otherwise disrupt sleep.

How should Flubest be stored and disposed of?

Flubest must be stored at Controlled Room Temperature, which is officially defined as between 20 C and 25 C (68 F and 77 F). The medication must not be frozen and should be kept away from excess moisture and heat to maintain its stability. It is required to keep the tablets in the original container, which must be tightly closed. As a measure for child safety, the product must be stored out of the sight and reach of children.

Disposal must follow local regulatory guidelines. Unused or expired Flubest should not be thrown into household trash or poured down a sink unless first mixed with an undesirable substance (e.g., coffee grounds) and sealed. The best option is to use an official drug take-back program.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Flubest found in:

A-Z Index: